A large number of CD8+ T cells continued to progress from central memory to terminal effect in the peripheral blood of patients with Parkinson’s disease (PD), and cytotoxic CD4+ T cells (CD4 CTLS) were significantly amplified from Th1 cells, providing valuable insights and rich resources for understanding adaptive immune responses in PD patients (40). The gene discussed is CD8A; the disease is Parkinson disease.